TTrialPathMatch Me to Trials
← Back to trials
RecruitingHistiocytosisLangerhans Cell HistiocytosisErdheim-Chester Disease

Histiocytic Disorder Follow-up Study

Eligible age

0–89 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of the study is to describe the burden of chronic health conditions, psychological dysfunction, chronic pain, healthcare utilization, worse health-related quality of life, overall mortality, and cause-specific mortality among individuals with histiocytic disorders

Sponsor: University of Alabama at Birmingham

You may qualify if…

  • diagnosis of histiocytic disorder at any age
  • 1. Langerhans cell histiocytosis,
  • 2. Erdheim-Chester disease,
  • 3. Rosai-Dorfman disease,
  • 4. Xanthogranuloma,
  • 5. Mixed histiocytosis
  • 6. Malignant histiocytosis (Histiocytic sarcoma, langerhans cell sarcoma, interdigitating cell sarcoma)
  • 7. Hemophagocytic lymphohistiocytosis

You may not qualify if…

  • None

Where it's recruiting

Alabama

Birmingham

Source: ClinicalTrials.gov · NCT05915208 · last updated 2026-06-12

Histiocytic Disorder Follow-up Study · TrialPath